Heron Therapeutics | HRTX - Dochód Netto





Dochód Netto Zmiana Data
ALKERMES USD 501K 66.98M 2026-06
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amarin USD -1.22M 6.51M 2025-12
ANI Pharmaceuticals USD 24.71M 4.78M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Emergent BioSolutions USD -261.3M 78.3M 2023-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
Merck USD -1.34B 2.9B 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 4.65M 1.74M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Veracyte USD 25.49M 3.22M 2026-06
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06